News

TipRanks on MSN11h
Alvo Minerals Launches $1.56 Million Entitlement Offer
An announcement from Alvo Minerals Limited ( ($AU:ALV) ) is now available. Alvo Minerals Limited has announced a pro-rata accelerated ...
CAPA - Centre for Aviation1d
As US airlines monitor close-in bookings, South American airlines cite solid near-term trends
US airlines are closely watching close-in booking trends, after demand softened in some passenger segments in 1Q2025. Copa ...
Zacks Investment Research on MSN1d
Wall Street Analysts Think Alvotech (ALVO) Could Surge 72.61%: Read This Before Placing a Bet
Shares of Alvotech (ALVO) have gained 10.1% over the past four weeks to close the last trading session at $10.66, but there ...
The Manila Times4d
Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami
Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar ...
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug
Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.
RDY & ALVO Ink Collaboration Deal for Merck's Keytruda Biosimilar
Dr. Reddy teams up with Alvotech to co-develop and commercialize a biosimilar of MRK's Keytruda, aiming to expand its biosimilars footprint.
Alvotech and Dr. Reddy’s partner to co-develop biosimilar candidate for Merck's Keytruda
Alvotech (ALVO) and Dr. Reddy’s Laboratories (RDY) have entered into a collaboration and license agreement to co-develop, ...
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Alvotech and Dr Reddy's enter into collaboration and license agreement for pembrolizumab
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (Alvotech), and Dr. Reddy's Laboratories announced that ...
Alvotech Completes Acquisition of Xbrane R&D Organization and biosimilar candidate to Cimzia®
Alvotech (NASDAQ: ALVO, ALVO-SDB), a global biotech company specializing in the development and manufacture of biosimilar ...